Resmed (RMD) Non Operating Income (2009 - 2026)

Resmed's Non Operating Income history runs 18 years deep, the most recent figure standing at $12.3 million for Q1 2026.

• Quarterly Non Operating Income rose 1449.43% year-over-year to $12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.0 million (up 249.66% YoY) and the FY2025 annual result came in at -$7.8 million, up 82.94% from the prior year.
• Non Operating Income was $12.3 million for Q1 2026 at Resmed, up from $7.9 million in the prior quarter.
• Across five years, Non Operating Income topped out at $12.3 million in Q1 2026 and bottomed at -$17.3 million in Q2 2022.
• A 5-year average of -$4.5 million and a median of -$3.8 million in 2024 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2024 — Non Operating Income tumbled 1019.57% — and 2026, when it soared 1449.43%.
• Resmed's Non Operating Income stood at -$6.5 million in 2022, then slumped by 140.5% to -$15.6 million in 2023, then soared by 106.9% to $1.1 million in 2024, then soared by 636.7% to $7.9 million in 2025, then soared by 54.57% to $12.3 million in 2026.
• Business Quant data shows RMD's Non Operating Income at $12.3 million in Q1 2026, $7.9 million in Q4 2025, and $256000.0 in Q3 2025.